Menu

CME Corner

Active Programs

Identifying and Diagnosing Interstitial Lung Disease

An early and accurate diagnosis of ILD and its specific type is vital to directing therapy and monitoring disease course and therapeutic response, but these conditions are commonly mischaracterized, and a correct diagnosis is often delayed. This activity will examine strategies for identifying and accurately diagnosing ILD. ...

  • Mobile + Online on Univadis Mobile + Online on Univadis
  • ACCME

Idiopathic Pulmonary Fibrosis: Developing Evidence-Based Management Plans

Treatment of ILD can be a challenge for clinicians; poor outcomes and health-related quality of life attest to the significant care gaps and treatment limitations that remain. Advances in the treatment of ILD, and particularly in idiopathic pulmonary fibrosis (IPF), hold promise for improved care and patient outcomes. This activity will examine management strategies for IPF. ...

  • Mobile + Online on Univadis Mobile + Online on Univadis
  • ACCME

Comprehensive Care in COPD: Strategies for Nurse Practitioners (Program ID: 18012973)

This activity will examine COPD risk factors, strategies for the recognition and assessment of early symptoms, criteria for diagnosis, and the implementation of a comprehensive patient-centered approach to disease management. *Learners will be redirected to the AANP website. ...

  • Online Presentation Online Presentation
  • AANP

The Changing Landscape of Interstitial Lung Disease

Many patients with interstitial lung disease (ILD) do not receive a timely and accurate diagnosis prior to considerable disease progression. Management guidelines are vague and treatment options have been limited, leading to negative health outcomes and decreased quality of life. Advances in diagnostic strategies, recently approved therapies, and new clinical trial data, however, are changing best ...

  • Online Presentation Online Presentation
  • ACCME

Diagnosis of Pediatric Allergic Asthma

In the United States, 8.6% of children (approximately 6.3 million) have asthma, and ~80% of these children have allergic asthma. This activity will review the epidemiology of pediatric allergic asthma and outline strategies for diagnosis, assessment of severity, and initial therapy. ...

  • Online Presentation Online Presentation
  • ACCME

Individualized Management of Pediatric Allergic Asthma

An evolving understanding of pediatric allergic asthma’s complex immunopathology is contributing to new treatment paradigms. This activity will examine the impact of asthma phenotypes and endotypes on treatment selection. ...

  • Online Presentation
  • ACCME

Expired Programs

Clinical Insights in Pediatrics: Improving Asthma Control by Optimizing Pharmacotherapy, Monitoring, and Patient Education

Millions of children and their families are affected by asthma, the most common chronic illness of childhood and the third leading cause of hospitalization among children under the age of 15. Pediatricians and pediatric nurse practitioners are uniquely positioned to care for children and adolescents with asthma, as they are heavily involved in the assessment, management, and follow-up of these pat ...

  • i-Newsletter i-Newsletter
  • ACCME
  • NAPNAP

Dialogue with the Experts: Strategies for Improving Interstitial Lung Disease Diagnosis and Treatment

An early and accurate diagnosis of ILD and its specific type is vital to directing therapy and monitoring disease course and therapeutic response, but these conditions are often mischaracterized and a correct diagnosis is very often delayed. This activity will examine recent advances in ILD diagnosis and treatment. ...

  • Video Roundtable Video Roundtable
  • ACCME

Updates on Molecular Testing in NSCLC

Oncologists have new options when treating advanced NSCLC. The use of molecular profiling to define subgroups of patients most likely to experience clinical benefit from novel targeted therapies has been endorsed by both ASCO and the National Comprehensive Cancer Network (NCCN).This activity will examine the role of molecular biomarkers in patients with advanced NSCLC. ...

  • Mobile + Online on Univadis
  • ACCME
Main Menu
EDITOR'S PICKS